Common use of Defined Term    Location Clause in Contracts

Defined Term    Location. Affected Party Section 13.7(f) Agreed Quarterly Budget Section 2.1(c) Arbitration Matter Section 15.7(b)(i) AstraZeneca Core IP Section 9.2(b) AstraZeneca Indemnitees Section 13.7(b) AstraZeneca Program IP Section 9.2(c) Bankruptcy Event Section 13.7(f) BIND Core IP Section 9.2(a) BIND Indemnitees Section 13.7(a) BIND Program IP Section 9.2(c) Claim Section 13.7(c) Competitive Infringement Section 11.1 Compound Claim Section 11.1 Confidential Information Section 12.1(a) Clinical Development & Commercialization Plan Section 4.1(c) Clinical Development & Commercialization Term Section 4.2(a) Confidentiality Agreement Section 12.5

Appears in 2 contracts

Sources: License Agreement (BIND Therapeutics, Inc), License Agreement (BIND Therapeutics, Inc)